Texas Bank & Trust Co Has $811,000 Stock Position in Aflac Incorporated $AFL

Texas Bank & Trust Co reduced its position in shares of Aflac Incorporated (NYSE:AFLFree Report) by 6.6% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,692 shares of the financial services provider’s stock after selling 540 shares during the period. Texas Bank & Trust Co’s holdings in Aflac were worth $811,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of AFL. NorthRock Partners LLC lifted its position in Aflac by 1.5% during the 1st quarter. NorthRock Partners LLC now owns 6,519 shares of the financial services provider’s stock worth $725,000 after acquiring an additional 95 shares during the last quarter. Valued Wealth Advisors LLC increased its stake in shares of Aflac by 24.4% in the first quarter. Valued Wealth Advisors LLC now owns 495 shares of the financial services provider’s stock worth $55,000 after purchasing an additional 97 shares during the period. Duncan Williams Asset Management LLC increased its stake in shares of Aflac by 5.0% in the second quarter. Duncan Williams Asset Management LLC now owns 2,065 shares of the financial services provider’s stock worth $218,000 after purchasing an additional 98 shares during the period. Stiles Financial Services Inc lifted its position in shares of Aflac by 3.4% during the 2nd quarter. Stiles Financial Services Inc now owns 3,070 shares of the financial services provider’s stock worth $324,000 after purchasing an additional 100 shares during the last quarter. Finally, Apexium Financial LP boosted its stake in Aflac by 3.4% during the 1st quarter. Apexium Financial LP now owns 3,103 shares of the financial services provider’s stock valued at $345,000 after purchasing an additional 103 shares during the period. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Joseph L. Moskowitz sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $102.57, for a total value of $102,570.00. Following the sale, the director directly owned 25,105 shares in the company, valued at approximately $2,575,019.85. This represents a 3.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

AFL has been the topic of a number of research analyst reports. UBS Group lowered their target price on Aflac from $114.00 to $111.00 and set a “neutral” rating on the stock in a report on Wednesday, August 6th. JPMorgan Chase & Co. raised their price objective on shares of Aflac from $96.00 to $100.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 8th. Wall Street Zen upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research note on Saturday, August 9th. Keefe, Bruyette & Woods increased their price target on shares of Aflac from $108.00 to $110.00 and gave the company a “market perform” rating in a report on Thursday, October 9th. Finally, Wells Fargo & Company raised their price target on shares of Aflac from $105.00 to $107.00 and gave the stock an “equal weight” rating in a research report on Monday, August 11th. Three equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $109.90.

Get Our Latest Research Report on Aflac

Aflac Stock Up 0.3%

Shares of AFL stock opened at $107.19 on Monday. Aflac Incorporated has a one year low of $96.95 and a one year high of $115.43. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.11 and a quick ratio of 0.11. The stock has a fifty day moving average price of $108.61 and a 200 day moving average price of $105.59. The stock has a market cap of $57.33 billion, a P/E ratio of 24.31, a price-to-earnings-growth ratio of 2.93 and a beta of 0.86.

Aflac (NYSE:AFLGet Free Report) last announced its quarterly earnings results on Monday, February 27th. The financial services provider reported $1.07 earnings per share (EPS) for the quarter. The firm had revenue of $5.91 billion for the quarter. Aflac had a net margin of 15.32% and a return on equity of 15.08%. Analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac announced that its Board of Directors has approved a stock buyback plan on Tuesday, August 12th that authorizes the company to repurchase 100,000,000 outstanding shares. This repurchase authorization authorizes the financial services provider to reacquire shares of its stock through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.

Aflac Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 2nd. Shareholders of record on Wednesday, August 20th were paid a dividend of $0.58 per share. The ex-dividend date was Wednesday, August 20th. This represents a $2.32 dividend on an annualized basis and a yield of 2.2%. Aflac’s dividend payout ratio (DPR) is currently 52.61%.

Aflac Company Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Read More

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.